Free Trial

William G. Bock Sells 1,000 Shares of Silicon Laboratories Inc. (NASDAQ:SLAB) Stock

Silicon Laboratories logo with Computer and Technology background

Silicon Laboratories Inc. (NASDAQ:SLAB - Get Free Report) Director William G. Bock sold 1,000 shares of the business's stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $149.43, for a total transaction of $149,430.00. Following the completion of the sale, the director now directly owns 31,115 shares in the company, valued at approximately $4,649,514.45. This represents a 3.11 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Silicon Laboratories Stock Down 2.1 %

NASDAQ SLAB traded down $3.37 on Friday, reaching $155.33. The company had a trading volume of 383,344 shares, compared to its average volume of 368,098. The company's fifty day moving average is $136.14 and its 200 day moving average is $119.75. Silicon Laboratories Inc. has a 52-week low of $94.00 and a 52-week high of $160.00. The stock has a market capitalization of $5.04 billion, a P/E ratio of -26.15 and a beta of 1.16.

Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last announced its earnings results on Tuesday, February 4th. The semiconductor company reported ($0.11) EPS for the quarter, meeting the consensus estimate of ($0.11). Silicon Laboratories had a negative net margin of 32.69% and a negative return on equity of 10.46%. The company had revenue of $166.25 million during the quarter, compared to the consensus estimate of $166.09 million. During the same quarter in the prior year, the company posted ($1.19) earnings per share. The firm's revenue for the quarter was up 91.4% on a year-over-year basis. On average, research analysts expect that Silicon Laboratories Inc. will post -0.97 EPS for the current year.

Hedge Funds Weigh In On Silicon Laboratories

Hedge funds and other institutional investors have recently modified their holdings of the business. FMR LLC increased its position in shares of Silicon Laboratories by 0.5% during the fourth quarter. FMR LLC now owns 4,867,203 shares of the semiconductor company's stock valued at $604,604,000 after acquiring an additional 23,833 shares during the last quarter. Vanguard Group Inc. grew its stake in shares of Silicon Laboratories by 1.9% during the 4th quarter. Vanguard Group Inc. now owns 3,959,580 shares of the semiconductor company's stock worth $491,859,000 after acquiring an additional 71,942 shares during the period. Capital Research Global Investors increased its stake in shares of Silicon Laboratories by 23.3% in the fourth quarter. Capital Research Global Investors now owns 2,131,920 shares of the semiconductor company's stock worth $264,827,000 after purchasing an additional 403,010 shares in the last quarter. Wellington Management Group LLP grew its stake in Silicon Laboratories by 28.3% in the 3rd quarter. Wellington Management Group LLP now owns 888,382 shares of the semiconductor company's stock valued at $102,670,000 after buying an additional 195,997 shares in the last quarter. Finally, Geode Capital Management LLC lifted its position in shares of Silicon Laboratories by 2.1% during the third quarter. Geode Capital Management LLC now owns 781,049 shares of the semiconductor company's stock worth $90,282,000 after acquiring an additional 15,728 shares in the last quarter.

Analysts Set New Price Targets

A number of brokerages have weighed in on SLAB. Stifel Nicolaus increased their price target on Silicon Laboratories from $135.00 to $145.00 and gave the stock a "buy" rating in a report on Monday, January 6th. Barclays raised their target price on Silicon Laboratories from $75.00 to $120.00 and gave the stock an "equal weight" rating in a research note on Friday, January 17th. StockNews.com lowered Silicon Laboratories from a "hold" rating to a "sell" rating in a research note on Friday, February 14th. KeyCorp increased their price target on Silicon Laboratories from $115.00 to $160.00 and gave the stock an "overweight" rating in a report on Wednesday, January 22nd. Finally, Susquehanna started coverage on shares of Silicon Laboratories in a research note on Tuesday, December 17th. They issued a "neutral" rating and a $130.00 price objective for the company. One analyst has rated the stock with a sell rating, five have assigned a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $136.20.

View Our Latest Report on Silicon Laboratories

Silicon Laboratories Company Profile

(Get Free Report)

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.

See Also

Should You Invest $1,000 in Silicon Laboratories Right Now?

Before you consider Silicon Laboratories, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silicon Laboratories wasn't on the list.

While Silicon Laboratories currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Goldman Sachs' 2025 Market Outlook: Top 3 Stock Picks

Goldman Sachs' 2025 Market Outlook: Top 3 Stock Picks

As Wall Street's 2025 predictions roll in, Goldman Sachs is focusing on manufacturing, energy, and domestic producers as key sectors for growth.

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines